EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA

Qian Liu, Abhishek K Verma, Xiaoqing Guan, Shengnan Qian, Stanley Perlman, Lanying Du iD

Cells · 04.12.2025 · 14 (23) · 1928

DOI: 10.3390/cells14231928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 04.12.2025. Verfasst von Qian Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Middle East Respiratory Syndrome Coronavirus, Spike Glycoprotein, Coronavirus, RNA, Messenger, Coronavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic Middle East respiratory syndrome CoV (MERS-CoV), first identified in Saudi Arabia in 2012, continues to pose a threat to public health. The trimeric spike (S) protein of MERS-CoV binds to the cellular receptor through the receptor-binding domain (RBD) in the S1 subunit to initiate virus entry and infection. Therefore, both the S protein and its RBD are targets for the development of MERS-CoV vaccines. Nevertheless, a direct comparison of the immune efficiency of S- and RBD-based MERS-CoV vaccines has not been made. Here, we compared two mRNA vaccines, respectively, targeting the S (S-mRNA) and RBD (RBD-mRNA) of MERS-CoV for their durable immunogenicity, neutralizing activity, and protective efficacy in a mouse model. Both mRNAs encapsulated with lipid nanoparticles (LNPs) maintained strong stability at various temperatures during the detection period. LNP-encapsulated RBD-mRNA elicited significantly higher and more durable antibodies than LNP-encapsulated S-mRNA, maintaining stronger and broadly neutralizing activity against the MERS-CoV original strain, as well as multiple variants containing key mutations within the RBD region. Importantly, RBD-mRNA provided durable protective efficacy against MERS-CoV infection in middle-aged mice, and this protection was associated positively with serum neutralizing antibody titers. Overall, this study identifies RBD-mRNA as an effective vaccine against MERS-CoV, with great potential for further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Middle East Respiratory Syndrome CoronavirusSpike Glycoprotein, CoronavirusRNA, MessengerCoronavirus InfectionsViral VaccinesImmunogenicity, VaccineAnimalsMiceAntibodies, NeutralizingAntibodies, ViralHumansFemaleMice, Inbred BALB CNanoparticles

Stichwörter der Autor:innen

MERS-CoVcoronavirusneutralizing activityprotective efficacyreceptor-binding domainspike

Substanzen

Spike Glycoprotein, CoronavirusRNA, MessengerAntibodies, NeutralizingAntibodies, ViralViral Vaccines

Autor:innen und Institutionen

  • Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
  • Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: Lanying Du

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Liu, Q., Verma, A. K., Guan, X., Qian, S., Perlman, S., & Du, L. (2025). MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA. Cells, 14(23), 1928. https://doi.org/10.3390/cells14231928

Vancouver

Liu Q, Verma AK, Guan X, Qian S, Perlman S, Du L. MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA. Cells. 2025;14(23):1928. doi:10.3390/cells14231928

BibTeX
@article{Liu2025,
  author = {Liu, Qian and Verma, Abhishek K and Guan, Xiaoqing and Qian, Shengnan and Perlman, Stanley and Du, Lanying},
  title = {MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {23},
  pages = {1928},
  doi = {10.3390/cells14231928}
}
Kostenlos starten →